Global trials push blood thinners into COVID-19 fight

Full-Dose Clot Prophylaxis Improves Outcomes in Moderate COVID-19

Blood thinners help hospitalized COVID-19 patients avoid ventilators, studies suggest

Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients in international trial

Trials Halt Full-Dose Clot Prophylaxis for Severe COVID-19

NIH ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients

International Trials of Blood Thinners in Critically Ill COVID-19 Patients Pause Due to Futility

International trials of blood thinners in critically ill COVID-19 patients pause due to futility

COVID and the city: COVID drug trials in Manitoba

Global clinical trial to test blood thinner on COVID-19 patients led by UM and UHN

Manitoba researchers launch global clinical trial that could improve survival of COVID-19

Global clinical trial test blood thinner on COVID-19 patients led by UM and UHN

Un essai clinique pour verifier si l'héparine peut traiter la COVID-19

Stepping Up: Manitoba research team focuses on testing potential therpaies for COVID-19

Santa Casa de Itabuna participa de estudo internacional sobre a COVID-19

Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)

Covid-19: Estudio para determinar si la anticoagulación terapéutica con heparina versus la atención habitual reduce la necesidad de intubación en pacientes hospitalizados con coronavirus